Using record linkage and manual follow-up to evaluate the Victorian maternal serum screening quadruple test for Down's syndrome, trisomy 18 and neural tube defects

Journal of Medical Screening

Volumn 13, Issue 1, 2006, Pages 8-13

  Jaques, Alice M ^a,b,c   Collins, Veronica R ^b   Haynes, Kerry ^b   Sheffield, Leslie J ^b,c,d   Francis, Ivan ^d   Forbes, Robin ^d   Halliday, Jane L ^a,c,e  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d Genetic Health Services Victoria   (Australia)

^e NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ANENCEPHALUS; ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SERUM; MEDICAL RECORD; MULTIPLE PREGNANCY; NEURAL TUBE DEFECT; PHYSICIAN; PREGNANCY OUTCOME; PRENATAL SCREENING; SCREENING TEST; SENSITIVITY ANALYSIS; SPINA BIFIDA; TRISOMY 18; AUSTRALIA; CHROMOSOME 18; INFORMATION PROCESSING; LABORATORY DIAGNOSIS; MASS SCREENING; METABOLISM; PREGNANCY; PRENATAL DIAGNOSIS; PROBABILITY; REPRODUCIBILITY; RISK; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; TRISOMY;

ADULT; ALPHA-FETOPROTEINS; CHROMOSOMES, HUMAN, PAIR 18; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASS SCREENING; MODELS, STATISTICAL; NEURAL TUBE DEFECTS; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; PROBABILITY; RECORDS; REPRODUCIBILITY OF RESULTS; RISK; SENSITIVITY AND SPECIFICITY; TRISOMY; VICTORIA;

EID: 33646850577     PISSN: 09691413     EISSN: 09691413     Source Type: Journal    
DOI: 10.1258/096914106776179782     Document Type: Article

References (33)

1. Muggli E, Halliday J. Prenatal diagnostic testing and Down syndrome in Victoria 1992-2002. Aust NZ J Publ Health 2004;28:465-70
2. Wald N, Huttly WJ, Hackshaw AK. Antenatal screening for Down's syndrome with the quadruple test. Lancet 2003;361:835-6
3. Palomaki G, Haddow J, Knight G, et al. Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin. Prenat Diagn 1995;15:713-23
4. Wald N, Hackshaw A, George L. Assay precision of serum alpha fetoprotein in antenatal screening for neural tube defects and Down's syndrome. J Med Screen 2000;7:74-7
5. Muggli E, Halliday J. Prenatal Diagnostic Testing in Victoria 2003. Melbourne: Murdoch Childrens Research Institute and Victorian Perinatal Data Collection Unit, Department of Human Services, 2004
6. HGSA/RANZCOG Joint Committee. Joint HGSA/RANZCOG recommended 'Best Practice' Guidelines on antenatal screening for Down syndrome and other fetal aneuploidy 2004;1-3. www.hgsa.com.au
7. Alberman E, Huttly W, Hennessy E, et al. The use of record linkage for auditing the uptake and outcome of prenatal serum screening and prenatal diagnostic tests for Down syndrome. Prenat Diagn 2003;23:801-6
8. Ward A. Organisation of screening programmes: a British experience. In: Grudzinskas J, Chard T, Chapman M, et al., eds. Screening for Down's syndrome. Chapter 15 Cambridge, UK: Cambridge University Press, 1994
9. Oats J. Routine antenatal screening: a need to evaluate Australian practice. Med J Australia 2000;172:311-2
10. Wald N, Densem J, George L, et al. Prenatal screening for Down's syndrome using inhibin-A as a serum marker. Prenat Diagn 1996;16:143-53
11. Wallace EM, Swanston I, McNeilly A, et al. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. Clin Endocrinol 1996;44:17-21
12. Wald N, Cuckle H, Densem K, et al. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 1988;297:883-7
13. Riley M, Griffin O. Validating a statewide data collection: differences in information technology resources between hospitals. Health Inform Manage 1997;27:67
14. Riley M, Phyland S, Halliday J. Validation study of the Victorian Birth Defects Register. J Paediatr Child Health 2004;40:544-8
15. Riley M, Howard J, Dale K, et al. Validating notifications of pregnancy terminations for birth defects before 20 weeks gestation. Health Inform Manage J 2001;30
16. Taylor R. Automated record linkage. In: Kerr C, Taylor R, Heard G, eds. Handbook of Public Health Methods. 1st edn. Sydney: The McGraw-Hill Companies Inc, 1998;184-7
17. Riley M, Halliday J. Births in Victoria 1999-2000. Melbourne: Perinatal Data Collection Unit, Victorian Government Department of Human Services, 2001
18. Nicolaides K. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstetr Gynecol 2004;191:45-67
19. Summers AM, Farrell SA, Huang T, et al. Maternal serum screening in Ontario using the triple marker test. J Med Screen 2003;10:107-11
20. Wald N, Rodeck C, Hackshaw AK, et al. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess 2003;7:1-88
21. Hackshaw A, Wald N. Inaccurate estimation of risk in second trimester serum screening for Down syndrome among women who have already had first trimester screening. Prenat Diagn 2001;21:741-6
22. Wald N, Kennard A, Hackshaw A, et al. Antenatal screening for Down's syndrome. J Med Screen 1997;4:181-246
23. Wright D, Bradbury I. Repeated measures screening for Down's Syndrome. BJOG: Int J Obstetr Gynaecol 2005;112:80-3
24. Saridogan E, Djahanbakhch O, Naftalin AA. Screening for Down's syndrome: experience in an inner city health district. Br J Obstetr Gynaecol 1996;103:1205-11
25. Marteau TM, Dormandy E. Facilitating informed choice in prenatal testing: how well are we doing? Am J Med Genet 2001;106:185-90
26. Gekas J, Gondry J, Mazur S, et al. Informed consent to serum screening for Down syndrome: are women given adequate information? Prenat Diagn 1999;19:1-7
27. Goel V, Glazier R, Holzapfel S, et al. Evaluating patient's knowledge of maternal serum screening. Prenat Diagn 1996;16:425-30
28. Mulvey S, Wallace E. Levels of knowledge of Down syndrome and Down syndrome testing in Australian women. Austr NZ J Obstetr Gynaecol 2001;41:167-9
29. Raeburn S. Evidence based screening for Down's syndrome. We should be prepared to re-examine entrenched practices. BMJ 2000;320:592-3
30. Tyzack K, Wallace E. Down syndrome screening: what do health professionals know? Austr NZ J Obstetr Gynaecol 2003;43:217-21
31. Metcalfe S, Hurworth R, Newstead J, et al. Needs assessment study of genetics education for general practitioners in Australia. Genet Med 2002;4:71-7
32. Sadler M. Serum screening for Down's syndrome: how much do health professionals know? Br J Obstetr Gynaecol 1997;104:176-9
33. Jaques A, Bell R, Watson L, et al. People who influence women's decisions and preferred sources of information about prenatal testing for birth defects. Austr NZ J Obstetr Gynaecol 2004;44:233-8